Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 9/20 | 0.57 |
| ▸ | PRSS1 | P07477 | 9/20 | 0.57 |
| ▸ | F7 | P08709 | 9/20 | 0.57 |
| ▸ | F10 | P00742 | 8/20 | 0.51 |
| ▸ | ESRRA | P11474 | 2/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.43 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.41 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.41 |
| ▸ | F3 | P13726 | 1/20 | 0.41 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.41 |
| ▸ | AR | P10275 | 1/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7140893 | 0.92 | F2 (0.59) | F2PRSS1F7F10CYP19A1 | |
| SCHEMBL5882326 | 0.91 | F2 (0.49) | F2PRSS1F7F10ESRRA | |
| SCHEMBL7146126 | 0.87 | F2 (0.57) | F2PRSS1F7F10CYP19A1 | |
| SCHEMBL7146130 | 0.87 | F2 (0.57) | F2PRSS1F7F10CYP19A1 | |
| SCHEMBL7143883 | 0.87 | F2 (0.55) | F2PRSS1F7F10CYP19A1 | |
| SCHEMBL7147539 | 0.87 | F2 (0.52) | F2PRSS1F7F10CYP19A1 | |
| SCHEMBL7147547 | 0.87 | F2 (0.52) | F2PRSS1F7F10CYP19A1 | |
| SCHEMBL7144188 | 0.86 | F7 (0.58) | F2PRSS1F7F10CYP19A1 | |
| SCHEMBL8128134 | 0.86 | F2 (0.52) | F2PRSS1F7F10CYP19A1 | |
| SCHEMBL7145102 | 0.86 | F2 (0.63) | F2PRSS1F7F10ESRRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0921116-B1 | N-(4-carbamimido-phenyl)-glycine amide derivatives | HOFFMANN LA ROCHE (CH) | 2003-06-18 | — | — | EP | disclosed |
| US-6140353-A | USED AS MEDICAMENTS FOR THE TREATMENT AND/OR PREVENTION OF THROMBOSES, APOPLEXY, CARDIAC INFARCTION, INFLAMMATION AND ARTERIOSCLEROSIS OR AS ANTITUMOR AGENTS | HOFFMANN-LA ROCHE INC. (US) | 2000-10-31 | — | — | US | disclosed |
| EP-0921116-A1 | N-(4-carbamimido-phenyl)-glycine amide derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1999-06-09 | — | — | EP | disclosed |